Therapeutics: ADP-ribosylation factor 6 (ARF6); G protein q polypeptide (GNAQ; G-ALPHA-q)

Cancer

INDICATION: Melanoma

Cell culture and mouse studies suggest inhibiting ARF6 could help treat GNAQ-mutant uveal

Read the full 148 word article

How to gain access

Continue reading with a
two-week free trial.